And a long (but still incomplete!) list of events I'm watching for this summer
I'm celebrating by writing a few hundred words on what the last 200 or so newsletters have taught me
And Cuban on the PBM campaign: 'so bad they will be ignored and forgotten quickly'
Plus more thinking on the next set of price-controlled meds
Plus a big-deal 340B bill drops, addressing the 'patient' definition and contract pharmacies
Plus a WSJ story that describes the problem, if not the solution, around cancer costs
And a new 340B appeals court decision hands pharma a decisive win
🙄🙄🙄🙄🙄
And even FDA officials think that the IRA is going to disrupt drug development
Plus: wonks rejoice! 'Stacking' is dead!
And Deep Dive Data Week continues with a look at hospital markups
And a little bit on delinkage, plus a study about how much Mark Cuban could save Medicare on cancer meds